Cardio Diagnostics Holdings is trading $1.88 (+9.65%) higher, with the move appearing sector-driven as healthcare outperforms.
- Healthcare is outperforming, supported by Bristol Myers Squibb’s approximately $2.3 billion Houston manufacturing investment.
- No new company-specific announcement dated August 11, 2026 was identified; the latest investor call announcement concerns August 20, 2026.
- Broader indexes remain mixed.